Flumazenil PSI 0.1mg/ml 5 pcs

Flumazenil PSI 0.1mg/ml Solution for Injection - Rapid Reversal of Benzodiazepine Sedation

Flumazenil PSI 0.1mg/ml solution is a critical medication designed for the rapid and effective reversal of the sedative effects of benzodiazepines. As a potent benzodiazepine antagonist, it is indispensable in clinical settings for awakening patients post-anesthesia or managing cases of benzodiazepine overdose.

For more details, you can refer to reputable sources such as Nahdi Online, , and for similar pharmaceutical products and their applications.

Benefits of Use:

Flumazenil offers several key benefits in medical practice:

• Rapidly reverses benzodiazepine-induced sedation.
• Facilitates quicker recovery and discharge post-anesthesia.
• Effective in managing benzodiazepine overdose by counteracting CNS depression.
• Enhances patient safety by restoring consciousness and respiratory drive.

How to Use:

Flumazenil PSI 0.1mg/ml is for intravenous administration only and should be administered by a qualified healthcare professional. Dosage is carefully titrated based on the patient's response and the indication.

1. Administer intravenously over 15 seconds.
2. For initial reversal of sedation, a typical dose is 0.2 mg.
3. If the desired level of consciousness is not obtained after 60 seconds, a further dose of 0.1 mg may be administered.
4. Repeat subsequent doses of 0.1 mg at 60-second intervals if necessary, up to a maximum cumulative dose of 1 mg.
5. For management of benzodiazepine overdose, the initial dose is typically 0.2 mg given over 30 seconds, followed by 0.3 mg over 30 seconds, then 0.5 mg over 30 seconds, with further doses of 0.5 mg at 60-second intervals up to a total dose of 3 mg.
6. Continuous infusion may be used in some cases to maintain the desired effect.
7. Careful monitoring of vital signs and level of consciousness is essential.

Caution & Warnings:

• Avoid in patients with known hypersensitivity to flumazenil or benzodiazepines.
• Use with extreme caution in patients who have been on long-term benzodiazepine therapy due to the risk of precipitating withdrawal symptoms, including seizures.
• Not recommended for routine reversal of sedation in non-emergency situations or in patients with serious underlying medical conditions without careful consideration of risks.
• Monitor closely for re-sedation, especially after short-acting benzodiazepines wear off.
• Patients with mixed drug overdose, especially involving tricyclic antidepressants, may be at increased risk of seizures or cardiac arrhythmias upon flumazenil administration.
• Pregnancy and lactation: Use only if the potential benefits outweigh the potential risks to the fetus or infant, as clinical data are limited.
• Driving and operating machinery: Patients should be warned not to drive or operate hazardous machinery for at least 24 hours after receiving flumazenil.

Ingredients:

Each ml of Flumazenil PSI 0.1mg/ml solution for injection contains:

• Active Ingredient: Flumazenil 0.1 mg
• Excipients: Sodium Chloride, Acetic Acid, Sodium Hydroxide (for pH adjustment), Water for Injection.

Product Details:

Flumazenil PSI 0.1mg/ml is a sterile, clear, colorless solution, free from visible particles, supplied in individual vials. It is intended for intravenous administration by medical professionals only.